Late-breaking abstract: Demographic trends and changes In long term outcome of incident idiopathic, heritable and anorexigen-associated pulmonary arterial hypertension between 2001 to 2009. Results from the Pulmonary Hypertension Registry of the United Kingdom and Ireland

Y. Ling, M. Johnson, D. Kiely, R. Condliffe, C. Elliot, S. Gibbs, L. Howard, J. Pepke-Zaba, K. Sheares, P. Corris, A. Fisher, J. Lordan, S. Gaine, G. Coghlan, J. Wort, M. Gatzoulis, A. Peacock (Clydebank, Sheffield, London, Papworth, Newcastle, United Kingdom; Dublin, Ireland)

Source: Annual Congress 2011 - Clinical features of human pulmonary hypertension
Session: Clinical features of human pulmonary hypertension
Session type: Oral Presentation
Number: 4909
Disease area: Interstitial lung diseases, Pulmonary vascular diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Y. Ling, M. Johnson, D. Kiely, R. Condliffe, C. Elliot, S. Gibbs, L. Howard, J. Pepke-Zaba, K. Sheares, P. Corris, A. Fisher, J. Lordan, S. Gaine, G. Coghlan, J. Wort, M. Gatzoulis, A. Peacock (Clydebank, Sheffield, London, Papworth, Newcastle, United Kingdom; Dublin, Ireland). Late-breaking abstract: Demographic trends and changes In long term outcome of incident idiopathic, heritable and anorexigen-associated pulmonary arterial hypertension between 2001 to 2009. Results from the Pulmonary Hypertension Registry of the United Kingdom and Ireland. Eur Respir J 2011; 38: Suppl. 55, 4909

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Late-breaking abstract: Short term improvement in 6 minute walk distance predicts long term survival in incident idiopathic pulmonary arterial hypertension. Results from the Pulmonary Hypertension Registry of the United Kingdom and Ireland
Source: Annual Congress 2011 - Treatment of pulmonary hypertension
Year: 2011


Clinical characteristics of pulmonary arterial hypertension in Ireland: results of a national register
Source: Annual Congress 2008 - Pulmonary arterial hypertension and other pulmonary vascular diseases
Year: 2008

Portopulmonary hypertension in United Kingdom: A contemporary, national, observational study
Source: International Congress 2014 – Pulmonary hypertension in lung disease
Year: 2014

Impact of treatment strategy in survival of patients with idiopathic pulmonary arterial hypertension. Real world evidence from Spanish National Pulmonary Hypertension Registry (REHAP)
Source: International Congress 2018 – Pulmonary hypertension: therapy
Year: 2018

Long term effects of traffic noise on chronic obstructive pulmonary disease (COPD) mortality in the Barcelona Metropolitan Region, 2004-2007
Source: International Congress 2014 – Risk factors for respiratory disease
Year: 2014


Incident pulmonary arterial hypertension in a Brazilian reference center: Results of a four-year registry
Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension I
Year: 2013


Long term clinical outcomes of bronchiectasis in India: Data from the EMBARC/RRNI Indian Bronchiectasis Registry
Source: Virtual Congress 2021 – Respiratory infections and bronchiectasis outcomes
Year: 2021



A USA-based registry for pulmonary arterial hypertension: 1982 2006
Source: Eur Respir J 2007; 30: 1103-1110
Year: 2007



Heterogeneity in bronchiectasis service provision in Europe: Baseline data from the European bronchiectasis registry (EMBARC)
Source: International Congress 2015 – Bronchiectasis and NTM infections: clinical aspects and research outlook
Year: 2015

Registries for paediatric pulmonary hypertension
Source: Eur Respir J 2013; 42: 580-583
Year: 2013


Incidence of idiopathic pulmonary fibrosis in Italy. Analysis of hospital admission and mortality databases of a large Italian region
Source: Annual Congress 2013 –Diffuse pulmonary fibrosis
Year: 2013

Impact of COPD in North America and Europe in 2000: subjects' perspective of Confronting COPD International Survey
Source: Eur Respir J 2002; 20: 799-805
Year: 2002



Assessing the financial impact of pulmonary hypertension: a survey by the UK Pulmonary Hypertension Association (PHA-UK)
Source: International Congress 2018 – Clinical aspects of pulmonary hypertension
Year: 2018

Trends in mortality from idiopathic pulmonary fibrosis in the European Union: an observational study of the WHO mortality database from 2001–2013
Source: Eur Respir J, 51 (1) 1701603; 10.1183/13993003.01603-2017
Year: 2018



ASPIRE registry: Assessing the Spectrum of Pulmonary hypertension Identified at a REferral centre
Source: Eur Respir J 2012; 39: 945-955
Year: 2012



Pregnancy and pulmonary hypertension: Experience of a reference center in Brazil
Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension II
Year: 2013


Determinants of diagnostic delay in chronic thromboembolic pulmonary hypertension: results from the European CTEPH Registry
Source: Eur Respir J, 52 (6) 1801687; 10.1183/13993003.01687-2018
Year: 2018



Association of pulmonary and cardiac manifestations in patients with primary antiphospholipid syndrome: A review of the Serbian national cohort study
Source: International Congress 2015 – Acute and chronic lung diseases: good clinical practice
Year: 2015

Risk categories from European guidelines applied to the French Pulmonary Hypertension (PH) registry
Source: International Congress 2017 – Outcomes and new treatment strategies in pulmonary hypertension
Year: 2017

Factor associated with global mortality in COPD between 2006 and 2011: French claims data
Source: Annual Congress 2013 –Risk factors for COPD and lung function decline
Year: 2013